GRASSILLI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 3.021
EU - Europa 2.033
AS - Asia 304
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 4
SA - Sud America 3
Totale 5.376
Nazione #
US - Stati Uniti d'America 2.967
DE - Germania 613
IT - Italia 600
SE - Svezia 231
CN - Cina 196
IE - Irlanda 161
GB - Regno Unito 129
UA - Ucraina 110
DK - Danimarca 58
CA - Canada 54
AT - Austria 37
HK - Hong Kong 31
VN - Vietnam 31
FI - Finlandia 27
IN - India 22
FR - Francia 19
RU - Federazione Russa 18
TR - Turchia 14
BE - Belgio 13
EU - Europa 11
RS - Serbia 5
CH - Svizzera 4
HU - Ungheria 3
IR - Iran 3
JP - Giappone 3
MU - Mauritius 3
CL - Cile 2
ES - Italia 2
KR - Corea 2
BG - Bulgaria 1
BR - Brasile 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
SG - Singapore 1
TW - Taiwan 1
Totale 5.376
Città #
Ann Arbor 1.312
Frankfurt am Main 519
Milan 300
Wilmington 243
Chandler 159
Dublin 157
Ashburn 136
Fairfield 134
Dearborn 114
Jacksonville 97
Houston 91
Woodbridge 91
New York 88
Princeton 57
Seattle 55
Cambridge 46
Mcallen 43
Vienna 35
Hong Kong 30
Nanjing 30
Shanghai 25
Guangzhou 24
Altamura 18
Boardman 17
Lachine 17
Lawrence 16
Ottawa 16
Lissone 14
Brussels 13
Segrate 13
Shenyang 13
Beijing 11
Nanchang 11
Kunming 10
Pune 10
Sacramento 10
San Diego 10
Toronto 10
Turin 10
Auburn Hills 9
Dong Ket 9
Edmonton 9
London 9
Los Angeles 9
Monza 9
Zhengzhou 9
Hebei 8
Tianjin 8
Changsha 7
Helsinki 7
Fremont 6
Jiaxing 6
Jinan 6
Council Bluffs 5
Halle 5
Napoli 5
Taizhou 5
Terni 5
Washington 5
Andover 4
Bergamo 4
Gavirate 4
Hangzhou 4
Kiev 4
Norwalk 4
Palermo 4
Rieti 4
Rome 4
San Mateo 4
Siena 4
Asti 3
Bologna 3
Budapest 3
Chicago 3
Chions 3
Falls Church 3
Hanoi 3
Magnago 3
Ningbo 3
Padova 3
Pavia 3
Phoenix 3
Annone di Brianza 2
Barcelona 2
Bovisio Masciago 2
Cambiago 2
Cermenate 2
Ciampino 2
Como 2
Daejeon 2
Eugene 2
Fano 2
Gallarate 2
Guwahati 2
Hefei 2
Montréal 2
Nürnberg 2
Pantigliate 2
Pomigliano d'Arco 2
San Fili 2
Totale 4.262
Nome #
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 472
Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy 440
Combinations of a btk inhibitor and fluorouracil for treating cancers 429
Pharmaceutical kit for use in the treatment of colon and colorectal cancer 388
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 352
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 351
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 345
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 298
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 273
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 271
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 248
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 184
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation 169
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 154
Methods for determining the sensitivity or resistance of cancer cells to at least one anticancer drug and/or therapeutically active molecule 138
Isoform of bruton's tyrosine kinase (BTK) protein 128
Isoform of bruton's tyrosine kinase (BTK) protein 127
Btk inhibitors for use in treating chemotherapeutic drug-resistant epithelial tumours 127
Isoform of Bruton's tyrosine kinase (BTK) protein 126
Modulator compounds of the drug resistance in epithelial tumour cells 121
Modulator compounds of the drug resistance in epithelial tumour cells 120
Modulator compounds of the drug resistance in epithelial tumour cells 104
NEW ISOFORM OF BRUTON’S TYROSINE KINASE (BTK) PROTEIN 104
Modulator compound of the drug resistance in epithelial tumor cells 85
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 70
Emerging actionable targets to treat therapy-resistant colorectal cancers 65
Editorial: Targeting Bruton Tyrosine Kinase 56
Identifying novel actionable targets in colon cancer 55
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression 52
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 25
BTK, the new kid on the (oncology) block? 24
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 20
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution? 19
Totale 5.940
Categoria #
all - tutte 14.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019134 0 0 0 0 0 0 0 0 0 46 25 63
2019/20201.067 78 62 87 72 95 130 136 85 103 105 102 12
2020/20211.359 67 29 135 128 122 135 134 139 110 145 98 117
2021/2022639 90 83 96 57 24 40 25 16 18 12 79 99
2022/20231.112 126 288 145 115 85 142 34 58 52 13 24 30
2023/2024557 32 22 27 61 57 153 110 37 15 43 0 0
Totale 5.940